Skip to content
OpenCapital
Get started

ICU Medical ICUI Derivative Liabilities - Fair Value

Derivative Liabilities - Fair Value at other companies

TFX
TeleflexTFX
$56.06M+96.4%
LivaNova logo
LivaNovaLIVN
$613K-31.4%
Baxter International logo
Baxter InternationalBAX
——
Edwards Lifesciences logo
Edwards LifesciencesEW
——
Medtronic logo
MedtronicMDT
——
Abbott logo
AbbottABT
——

Other financials

Income statement

See full
Revenue$530.2M-12.3%
Gross profit$206.2M-1.8%
Operating income$13.6M+5.4%
Net income$30.1M+295%
EPS (diluted)$1.20+290%

Balance sheet

See full
Cash & equivalents$288.3M-0.5%
Total debt$1.4B-17.5%
Total equity$2.1B+6.3%
Total assets$4.0B-4.1%

Cash flow

See full
Operating cash flow$38.9M-24.2%
CapEx$11.3M-22.7%
Free cash flow$27.6M-24.8%

Valuation

See full
Market cap$3.39B-6.3%

Profitability

See full
Gross margin37.9%+2.8pp
Operating margin2%-0.7pp
Net margin-0.3%-0.2pp
FCF margin4.2%-1.2pp

Returns & leverage

See full
Return on equity-0.4%-0.2pp
Debt / equity0.6×-0.2×
Current ratio2.3×-0.3×

Where this comes from

Reported directly by ICU Medical in its filing.

Tagged under the XBRL concept us-gaap:DerivativeLiabilitiesCurrent.

The official record: ICU Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ICU Medical's derivative liabilities - fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ICU Medical's derivative liabilities - fair value?
ICU Medical (ICUI) reported derivative liabilities - fair value of $4.91M in Q1 2026.
How has ICU Medical's derivative liabilities - fair value changed year-over-year?
ICU Medical's derivative liabilities - fair value increased by 13.3% year-over-year, from $4.34M to $4.91M.
What does derivative liabilities - fair value mean?
This metric represents the total fair market value of all derivative contracts currently in a liability position for the institution. It reflects the potential cash outflow required if these contracts were settled at the current reporting date. Monitoring this value is essential for assessing the bank's exposure to market volatility and counterparty risk.